News
03-15-2010, 05:21 AM
BioSante Pharmaceuticals, Inc. today announced BioSante’s receipt of Orphan Drug designation from the FDA’s Office of Orphan Products Development for GVAX Pancreas Vaccine in the treatment of pancreatic cancer.
More... (http://www.news-medical.net/news/20100315/BioSante-Pharmaceuticals-receives-receipt-of-Orphan-Drug-designation-for-GVAX-Pancreas-Vaccine.aspx)
More... (http://www.news-medical.net/news/20100315/BioSante-Pharmaceuticals-receives-receipt-of-Orphan-Drug-designation-for-GVAX-Pancreas-Vaccine.aspx)